Rhythm Pharmaceuticals (RYTM) Inventory Average (2023 - 2026)

Rhythm Pharmaceuticals (RYTM) has 4 years of Inventory Average data on file, last reported at $27.2 million in Q1 2026.

• Inventory Average for Q1 2026 came in at $27.2 million, up 42.95% year-over-year; the trailing twelve-month figure through Mar 2026 was $27.2 million (up 42.95% YoY), and the FY2025 annual result was $22.2 million, up 62.59% from the prior year.
• Inventory Average improved to $27.2 million in Q1 2026 per RYTM's latest filing, from $23.9 million in the prior quarter.
• Over five years, Inventory Average peaked at $27.2 million in Q1 2026 and troughed at $4.2 million in Q1 2023.
• A 4-year average of $14.1 million and a median of $12.9 million in 2024 frame the typical range for Inventory Average.
• The sharpest annual moves came in 2025 and 2026: Inventory Average soared 122.15% in 2025, then soared 42.95% in 2026.
• A 4-year view of Inventory Average shows it stood at $8.2 million in 2023, then soared by 99.17% to $16.3 million in 2024, then surged by 46.65% to $23.9 million in 2025, then climbed by 13.67% to $27.2 million in 2026.
• Business Quant data shows RYTM's Inventory Average at $27.2 million in Q1 2026, $23.9 million in Q4 2025, and $20.5 million in Q3 2025.